Obesity paradox and perioperative myocardial infarction/injury in non-cardiac surgery

[1]  K. Khunti,et al.  Meta‐analysis of the influence of lifestyle changes for preoperative weight loss on surgical outcomes , 2018, The British journal of surgery.

[2]  O. Barbarash,et al.  FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. FOCUS ON THE TYPE 2 MYOCARDIAL INFARCTION , 2018, Fundamental and Clinical Medicine.

[3]  Jeroen J. Bax,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Circulation.

[4]  Jeroen J. Bax,et al.  [Fourth universal definition of myocardial infarction (2018)]. , 2018, Kardiologia polska.

[5]  G. Guyatt,et al.  Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial , 2018, The Lancet.

[6]  B. Schroen,et al.  Sex‐specific associations of obesity and N‐terminal pro‐B‐type natriuretic peptide levels in the general population , 2018, European journal of heart failure.

[7]  M. Packer.  Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium. , 2018, Journal of the American College of Cardiology.

[8]  Craig M. Hales,et al.  Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016 , 2018, JAMA.

[9]  M. Seeberger,et al.  Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization , 2017, Circulation.

[10]  R. Twerenbold,et al.  Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[11]  Pavel S. Roshanov,et al.  Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery , 2017, JAMA.

[12]  K. Rentsch,et al.  Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction. , 2016, American heart journal.

[13]  S. Blair,et al.  Obesity and Cardiovascular Disease , 2006 .

[14]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials , 2015, Journal of Nuclear Cardiology.

[15]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). , 2015, Circulation.

[16]  B. Gorenek,et al.  2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). , 2014, European journal of anaesthesiology.

[17]  B. Gorenek,et al.  ESC / ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management , 2014 .

[18]  R. Stolker,et al.  Impact of Obesity on Postoperative and Long-term Outcomes in a General Surgery Population: A Retrospective Cohort Study , 2013, World Journal of Surgery.

[19]  R. Stolker,et al.  The obesity paradox in the surgical population , 2013, BDJ.

[20]  The obesity paradox in the surgical population , 2013, BDJ.

[21]  D. Grobbee,et al.  An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk , 2011, PloS one.

[22]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[23]  A. Jaffe,et al.  Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. , 2009, Clinical chemistry.

[24]  W. Henderson,et al.  The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. , 2009, Journal of vascular surgery.

[25]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[26]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[27]  F. Neumann,et al.  The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. , 2007, European heart journal.

[28]  K. Walsh,et al.  Adiponectin actions in the cardiovascular system. , 2007, Cardiovascular research.

[29]  W. James,et al.  Effect of Plain Versus Sugar‐Sweetened Breakfast on Energy Balance and Metabolic Health: A Randomized Crossover Trial , 2020, Obesity.

[30]  P. Clavien,et al.  Obesity in general elective surgery , 2003, The Lancet.

[31]  K. Kalantar-Zadeh,et al.  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. , 2003, Kidney international.

[32]  H. White,et al.  Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. , 2001, Journal of clinical epidemiology.

[33]  E F Cook,et al.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[34]  A. Agresti,et al.  Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions , 1998 .